Interactions of PLGA nanoparticles with blood components: Protein adsorption, coagulation, activation of the complement system and hemolysis studies

Nanoscale

Volumn 7, Issue 14, 2015, Pages 6045-6058

  Fornaguera, Cristina ^a   Calderó, Gabriela ^a   Mitjans, Montserrat ^b   Vinardell, Maria Pilar ^b   Solans, Conxita ^a   Vauthier, Christine ^c  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; COAGULATION; COPOLYMERS; NANOPARTICLES; PROTEINS;

COMPLEMENT ACTIVATIONS; COMPLEMENTARY TECHNIQUES; INTRAVENOUS ADMINISTRATION; NANOPARTICLE FUNCTIONALIZATION; NANOPARTICLE PROPERTIES; NANOPARTICLE SURFACE CHARGE; POLY LACTIC-CO-GLYCOLIC ACID; SATURATION CONCENTRATION;

BLOOD;

LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ADSORPTION; ANIMAL; BLOOD CLOTTING; BOVINE; CHEMISTRY; COMPLEMENT ACTIVATION; HEMOLYSIS; HUMAN;

ADSORPTION; ANIMALS; BLOOD COAGULATION; CATTLE; COMPLEMENT ACTIVATION; HEMOLYSIS; HUMANS; LACTIC ACID; NANOPARTICLES; POLYGLYCOLIC ACID;

EID: 84963966190     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c5nr00733j     Document Type: Article

References (51)

1. C. Pinto Reis R. J. Neufeld A. J. Ribeiro F. Veiga Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles Nanomed. Nanotechnol. Biol. Med. 2006 2 1 8 21
2. M. A. Dobrovolskaia P. Aggarwal J. B. Hall S. E. McNeil Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution Mol. Pharm. 2008 5 4 487 495
3. A. Kumari S. K. Yadav S. C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf., B 2010 75 1 1 18
4. S. Mura P. Couvreur Nanotheranostics for personalized medicine Adv. Drug Delivery Rev. 2012 64 13 1394 1416
5. J. Nicolas S. Mura D. Brambilla N. Mackiewicz P. Couvreur Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery Chem. Soc. Rev. 2013 42 1147 1235
6. M. A. Dobrovolskaia and S. McNeil, Handbook of immunological properties of engineered nanomaterials, Frontiers in Nanobiomedical research, SAIC-Frederick, Inc., USA, 2013
7. J. Kreuter Nanoparticle-based drug delivery systems J. Controlled Release 1991 16 169 176
8. D. Labarre C. Vauthier C. Chauvierre B. Petri R. Müller M. M. Chehimi Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush Biomaterials 2005 26 5075 5084
9. R. Alyautdin I. Khalin M. I. Nafeeza M. H. Haron D. Kuznetsov Nanoscale drug delivery systems and the blood-brain barrier Int. J. Nanomed. 2014 9 795 811
10. M. Dobrovolskaia S. McNeil Immunological properties of engineered nanomaterials Nat. Nanotechnol. 2007 2 469 478
11. E. Cenni D. Granchi S. Avnet C. Fotia M. Salerno D. Micieli M. G. Sarpietro R. Pignatello F. Castelli N. Baldini Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate Biomaterials 2008 29 1400 1411
12. C. Vauthier B. Persson P. Linder B. Cabane Protein adsorption and complement activation for di-block copolymer nanoparticles Biomaterials 2011 32 1646 1656
13. T. Blunk D. F. Hochstrasser J. C. Sanchez B. W. Miiller R. H. Miillelj Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis Electrophoresis 1993 14 1382 1387
14. M. Cavadas A. González-Fernández R. Franco Pathogen-mimetic stealth nanocarriers for drug delivery: a future possibility Nanomed. Nanotechnol. Biol. Med. 2011 7 6 730 743
15. I. Lynch K. A. Dawson Protein-nanoparticle interactions Nano Today 2008 3 1-2 40 47
16. C. Vauthier P. Lindner B. Cabane Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona Colloids Surf., B 2009 69 207 215
17. S. M. Moghimi A. J. Andersen D. Ahmadvand P. P. Wibroe T. L. Andresen A. C. Hunter Material properties in complement activation Adv. Drug Delivery Rev. 2011 63 1000 1007
18. J. Sbezini P. Bedocs D. Csukás L. Rosivall R. Bünger R. Urbaniks A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines Adv. Drug Delivery Rev. 2012 64 1706 1716
19. M. A. Dobrovolskaia A. K. Patri J. Zheng J. D. Clogston N. Ayub P. Aggarwal B. W. Neum J. B. Hall S. McNeil Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles Nanomedicine 2009 5 106 117
20. H. Sahli J. Tapon-Bretaudière A. M. Fischer C. Sternberg G. Spenlehauer T. Verrecchia D. Labarre Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system Biomaterials 1997 18 281 288
21. C. Salvador-Morales L. Zhang R. Langer O. C. Farokhzad Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups Biomaterials 2009 30 2231 2240
22. R. M. Aparicio M. J. García-Celma M. P. Vinardell M. Mitjans In vitro studies of the hemolytic activity of microemulsions in human erythrocytes J. Pharm. Biomed. Anal. 2005 39 1063 1067
23. R. H. Müller K. H. Wallis Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908 Int. J. Pharm. 1993 89 25 31
24. S. Stolnik S. E. Dunn M. C. Garnett M. C. Davies A. G. A. Coombes D. C. Taylor M. P. Irving S. C. Prkiss T. F. Tadros S. S. Davis L. Illum Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glicol) copolymers Pharm. Res. 1994 11 12 1800 1808
25. R. Gref A. Domb P. Quellec T. Blunk R. H. Müller J. M. Verbavatz R. Langer The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres Adv. Drug Delivery Rev. 2012 64 316 326
26. V. C. F. Mosqueira P. Legrand A. Gulik O. Bourdon R. Gref D. Labarre G. Barratt Relationship between complement activation, cellullar uptake and surface physicochemical aspects of novel PEG-modified nanocapsules Biomaterials 2001 22 2967 2979
27. D. Kim H. El-Shall D. Dennis T. Morey Interaction of PLGA nanoparticles with human blood constituents Colloids Surf., B 2005 40 83 91
28. S. M. D'Addio W. Saad S. M. Ansell J. J. Squiers D. H. Adamson M. Herrera-Alonso A. R. Wohl T. R. Hoye C. W. Macosko L. D. Mayer C. Vauthier R. K. Prud'homme Effects of block copolymer properties on nanocarrier protection from in vivo clearance J. Controlled Release 2012 162 1 208 217
29. C. Solans I. Solè Nano-emulsions: Formation by low-energy methods Curr. Opin. Colloid Interface Sci. 2012 17 246 254
30. G. Calderó M. J. García-Celma C. Solans Formation of polymeric nano-emulsions by a low-energy method and their use for nanoparticle preparation J. Colloid Interface Sci. 2011 353 2 406 411
31. C. Fornaguera S. Grijalvo M. Galán E. Fuentes-Paniagua F. J. de la Mata R. Gómez R. Eritja G. Calderó C. Solans Novel non-viral gene delivery systems composed of carbosilane dendron functionalized nanoparticles prepared from nano-emulsions as non-viral carriers for antisense oligonucleotides Int. J. Pharm. 2015 478 1 113 123
32. S. Stolnik M. C. Garnett L. Illum M. Bousta M. Vert S. S. Davis The colloidal properties of surfactant-free biodegradable nanospheres from poly(b-malic acid-co-benzyl malate)s and poly(lactic acid-co-glycolide) Colloids Surf., A 1995 97 235 245
33. C. Vauthier K. Bouchemal Methods for the preparation and manufacture of polymeric nanoparticles Pharm. Res. 2009 26 5 1025 1058
34. S. A. Kulkarni S. S. Feng Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery Pharm. Res. 2013 30 2512 2522
35. B. Neha B. Ganesh K. Preeti Drug delivery to the brain using polymeric nanoparticles: a review Int. J. Pharm. Life Sci. 2013 2 3 107 132
36. J. Kreuter Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv. Drug Delivery Rev. 2014 71 2 14
37. A. V. Delgado F. González-Caballero R. J. Hunter L. K. Koopal Measurement and interpretation of electrokinetic phenomena J. Colloid Interface Sci. 2007 309 194 224
38. I. Bertholon C. Vauthier D. Labarre Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length and type of polysaccharide Pharm. Res. 2006 23 6 1313 1323
39. Y. M. Thasneem S. Sajeesh C. P. Sharma Effect of thiol functionalization on the hemo-compatibility of PLGA nanoparticles J. Mater. Res. 2011 99 4 607 617
40. O. Harush-Frenkel N. Debotton S. Benita Y. Altschuler Targeting of nanoparticles to the clathrin-mediated encodytic pathway Biochem. Biophys. Res. Commun. 2007 353 26 32
41. R. P. Singh P. Ramarao Accumulated polymer degradation productes as effector molecules in cytotoxicity of polymeric nanoparticles Toxicol. Sci. 2013 136 1 131 143
42. T. Verrecchia G. Spenlehauer D. V. Bazile A. Murry-Brelier Y. Archimbaud M. Veillard Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers J. Controlled Release 1995 36 49 61
43. J. C. Olivier C. Vauthier M. Taverna D. Ferrier P. Couvreur Preparation and characterization of biodegradable poly(isobutylcyano acrylate) nanoparticles with the surface modified by the adsorption of proteins Colloids Surf., B 1995 4 349 356
44. D. F. Moyano K. Saha G. Prakash B. Yan H. Kong M. Yazdani V. M. Rotello Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity ACS Nano 2014 8 7 6748 6755
45. K. Chen S. Rana D. F. Moyano Y. Xu X. Guo V. M. Rotello Optimizing the selective recognition of protein isoforms through tuning of nanoparticle hydrophobicity Nanoscale 2014 6 6492 6495
46. J. D. Byrne T. Betancourt L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Delivery Rev. 2008 60 15 1615 1626
47. C. T. N. Pham L. M. Mitchell J. L. Huang C. M. Lubniewski O. S. Schall J. K. Killgore D. Pan S. A. Wickline G. M. Lanza D. E. Hourcade Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces J. Biol. Chem. 2011 286 123 130
48. C. Zandanel C. Vauthier Poly(isobutylcyanoacrylate) Nanoparticles Decorated with Chitosan: Effect of Conformation of Chitosan Chains at the Surface on Complement Activation Properties J. Colloid Sci. Biotechnol. 2012 1 1 68 81
49. S. M. Moghimi J. Szebeni Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties Prog. Lipid Res. 2012 42 463 478
50. A. Vonarbourg C. Passirani P. Saulnier J. P. Benoit Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 2008 27 4356 4373
51. R. Minchin Nanomedicine: Sizing up targets with nanoparticles Nat. Nanotechnol. 2008 3 12 13